Following a six-month follow-up, rapid hematologic reconstitution and persistence of editing rates that led to increased HbF expression were observed in SCD patients who remained symptom-free at 52 and 32 weeks and 29 days post-transplantation of CD34+-edited cells [170]. The gene discussed is CD34; the disease is Schnyder corneal dystrophy.